The legacy of Viagra and its effect on the healthcare landscape presents a intriguing question for potential backers. Initially a blockbuster drug, copycat medications have significantly chipped away at its market dominance, creating difficulties for companies connected to the original patent holder and subsequent formulas. While certain companies